Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(2)
ODS 3: Salud y bienestar(2)
ODS 9: Industria, innovación e infraestructura(2)
Origen
scopus(2)
RacGAP1 is a novel downstream effector of E2F7-dependent resistance to doxorubicin and is prognostic for overall survival in squamous cell carcinoma
ArticleAbstract: We have previously shown that E2F7 contributes to drug resistance in head and neck squamous cell carPalabras claves:Autores:Boros S., Dantzic D.D.E., De Long L.M., Dzienis M., Gannon O.M., Hazar-Rethinam M., Mukhopadhyay P., Natalia Sáenz-Ponce, Saunders N.A., Simpson F., Vargas A.C.Fuentes:scopusTargeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas
ArticleAbstract: Patient mortality rates have remained stubbornly high (40%) for the past 35 years in head and neck sPalabras claves:Autores:Argueta C., Boros S., Daelemans D., De Long L.M., Gannon O.M., Hazar-Rethinam M., Jacquemyn M., Kashyap T., Landesman Y., Natalia Sáenz-Ponce, Panizza B., Pillay R., Saunders N.A.Fuentes:scopus